Literature DB >> 28956140

Cognitive Behavioral Analysis System of Psychotherapy as group psychotherapy for chronically depressed inpatients: a naturalistic multicenter feasibility trial.

Lena Sabaß1,2, Frank Padberg3, Claus Normann4, Vera Engel4, Carsten Konrad5,6, Kristina Helmle5, Andrea Jobst3, Andrew Worlitz7, Eva-Lotta Brakemeier8,9.   

Abstract

The Cognitive Behavioral Analysis System of Psychotherapy (CBASP) is a relatively new approach in the treatment of chronic depression (CD). Adapted as group psychotherapy for inpatients, CBASP is attracting increasing attention. In this naturalistic multicenter trial, we investigated its feasibility after 10 sessions of CBASP group therapy over a treatment time of at least 5 to a maximum of 10 weeks. Treatment outcome was additionally assessed. Across four centers, 116 inpatients with CD (DSM-IV-TR) attended CBASP group psychotherapy. Feasibility was focused on acceptance, and evaluated for patients and therapists after five (t1) and ten sessions (t2) of group psychotherapy. Observer- and self-rating scales (Hamilton Depression Rating Scale-24 items, HDRS24; Beck Depression Inventory-II, BDI-II; World Health Organization Quality of Life assessment, WHOQOL-BREF) were applied before group psychotherapy (t0) and at t2. Dropouts were low (10.3%). Patients' evaluation improved significantly from t1 to t2 with a medium effect size (d = 0.60). Most of the patients stated that the group had enriched their treatment (75.3%), that the size (74.3%) and duration (72.5%) were 'optimal' and 37.3% wished for a higher frequency. Patients gave CBASP group psychotherapy an overall grade of 2 ('good'). Therapists' evaluation was positive throughout, except for size of the group. Outcome scores of HDRS24, BDI-II, and WHOQOL-BREF were significantly reduced from t0 to t2 with medium to large effect sizes (d = 1.48; d = 1.11; d = 0.67). In this naturalistic open-label trial, CBASP, when applied as inpatient group psychotherapy, was well accepted by patients and therapists. The results point towards a clinically meaningful effect of inpatient treatment with CBASP group psychotherapy on depression and quality of life. Other potential factors that could have promoted symptom change were discussed. A future controlled study could investigate the safety and efficacy of CBASP group psychotherapy for inpatients.

Entities:  

Keywords:  CBASP; Chronic depression; Cognitive Behavioral Analysis System of Psychotherapy; Depression; Feasibility; Group psychotherapy; Inpatient

Mesh:

Year:  2017        PMID: 28956140     DOI: 10.1007/s00406-017-0843-5

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  33 in total

1.  Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study.

Authors:  D N Klein; J E Schwartz; S Rose; J B Leader
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

2.  THINKING AND DEPRESSION. II. THEORY AND THERAPY.

Authors:  A T BECK
Journal:  Arch Gen Psychiatry       Date:  1964-06

3.  Overcoming treatment resistance in chronic depression: a pilot study on outcome and feasibility of the cognitive behavioral analysis system of psychotherapy as an inpatient treatment program.

Authors:  Eva-Lotta Brakemeier; Martina Radtke; Vera Engel; Johannes Zimmermann; Brunna Tuschen-Caffier; Martin Hautzinger; Elisabeth Schramm; Mathias Berger; Claus Normann
Journal:  Psychother Psychosom       Date:  2014-12-24       Impact factor: 17.659

4.  Depression, self-focused attention, and expectancies for positive and negative future life events for self and others.

Authors:  T Pyszczynski; K Holt; J Greenberg
Journal:  J Pers Soc Psychol       Date:  1987-05

5.  Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission?

Authors:  Mark Zimmerman; Jennifer A Martinez; Naureen Attiullah; Michael Friedman; Cristina Toba; Daniela A Boerescu; Moataz Rahgeb
Journal:  J Clin Psychiatry       Date:  2012-04-17       Impact factor: 4.384

6.  Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for chronic depression: clinical characteristics and six month clinical outcomes in an open case series.

Authors:  John S Swan; Robert Macvicar; David Christmas; Rob Durham; Petra Rauchhaus; James P McCullough; Keith Matthews
Journal:  J Affect Disord       Date:  2013-10-05       Impact factor: 4.839

7.  Prevalence and correlates of chronic depression in the canadian community health survey: mental health and well-being.

Authors:  Satyendra Satyanarayana; Murray W Enns; Brian J Cox; Jitender Sareen
Journal:  Can J Psychiatry       Date:  2009-06       Impact factor: 4.356

Review 8.  European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe.

Authors:  A Jobst; E-L Brakemeier; A Buchheim; F Caspar; P Cuijpers; K P Ebmeier; P Falkai; R Jan van der Gaag; W Gaebel; S Herpertz; T Kurimay; L Sabaß; K Schnell; E Schramm; C Torrent; D Wasserman; J Wiersma; F Padberg
Journal:  Eur Psychiatry       Date:  2016-02-06       Impact factor: 5.361

Review 9.  The treatment of chronic depression with cognitive behavioral analysis system of psychotherapy: a systematic review and meta-analysis of randomized-controlled clinical trials.

Authors:  Philip Negt; Eva-Lotta Brakemeier; Johannes Michalak; Lotta Winter; Stefan Bleich; Kai G Kahl
Journal:  Brain Behav       Date:  2016-05-03       Impact factor: 2.708

10.  Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial.

Authors:  Elisabeth Schramm; Levente Kriston; Ingo Zobel; Josef Bailer; Katrin Wambach; Matthias Backenstrass; Jan Philipp Klein; Dieter Schoepf; Knut Schnell; Antje Gumz; Paul Bausch; Thomas Fangmeier; Ramona Meister; Mathias Berger; Martin Hautzinger; Martin Härter
Journal:  JAMA Psychiatry       Date:  2017-03-01       Impact factor: 21.596

View more
  7 in total

1.  Cognitive Behavioral Analysis System of Psychotherapy for inpatients with persistent depressive disorder: a naturalistic trial on a general acute psychiatric unit.

Authors:  Anne Guhn; Stephan Köhler; Eva-Lotta Brakemeier; Philipp Sterzer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-07-12       Impact factor: 5.270

2.  Investigating the feasibility and effectiveness of a modular treatment program for children and adolescents with depression and interpersonal problems: study protocol of a quasi-experimental pilot feasibility trial (CBASP@YoungAge).

Authors:  H Christiansen; E-L Brakemeier; N Dippel; T In-Albon; S Schneider
Journal:  Pilot Feasibility Stud       Date:  2022-07-11

3.  Group Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for persistently depressed outpatients: a retrospective chart review.

Authors:  Marieke R Potijk; Marije Aan Het Rot; Frieda M Parlevliet; Robert A Schoevers; Marieke J Eldering
Journal:  Br J Clin Psychol       Date:  2020-09-13

4.  Interpersonal Change During Inpatient CBASP Treatment: Focus on Group Therapy.

Authors:  Anne Guhn; David Schön; Yvonne Zische; Philipp Sterzer; Stephan Köhler
Journal:  Front Psychiatry       Date:  2021-02-26       Impact factor: 4.157

5.  Borderline Personality Features in Patients With Persistent Depressive Disorder and Their Effect on CBASP Outcome.

Authors:  Franziska Konvalin; Fabienne Grosse-Wentrup; Tabea Nenov-Matt; Kai Fischer; Barbara B Barton; Stephan Goerigk; Eva-Lotta Brakemeier; Richard Musil; Andrea Jobst; Frank Padberg; Matthias A Reinhard
Journal:  Front Psychiatry       Date:  2021-03-12       Impact factor: 4.157

6.  Adding an App-Based Intervention to the Cognitive Behavioral Analysis System of Psychotherapy in Routine Outpatient Psychotherapy Treatment: Proof-of-Concept Study.

Authors:  Anna-Lena Netter; Ina Beintner; Eva-Lotta Brakemeier
Journal:  JMIR Form Res       Date:  2022-08-09

7.  Group Cognitive Behavioral Analysis System of Psychotherapy (CBASP): A Pilot Study for Bipolar Depression.

Authors:  Liliane Sayegh; El Hadj Touré; Elisabeth Farquhar; Serge Beaulieu; Suzane Renaud; Soham Rej; Michel Perreault
Journal:  Front Psychiatry       Date:  2020-09-23       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.